SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Claire Elizabeth Payne, Adam R Brown, Jonathon W Theile, Alexandre J C Loucif, Aristos J Alexandrou, Mathew D Fuller, John H Mahoney, Brett M Antonio, Aaron C Gerlach, David M Printzenhoff, Rebecca L Prime, Gillian Stockbridge, Anthony J Kirkup, Anthony W Bannon, Steve England, Mark L Chapman, Sharan Bagal, Rosemarie Roeloffs, Uma Anand, Praveen Anand, Peter J Bungay, Mark Kemp, Richard P Butt, Edward B Stevens, A novel selective and orally bioavailable Nav1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability, British Journal of Pharmacology, 2015, 172, 10
  2. 2
    Marko Jukič, Rok Frlan, Fiona Chan, Robert W. Kirby, David J. Madge, Jan Tytgat, Steve Peigneur, Marko Anderluh, Danijel Kikelj, Synthesis and biological evaluation of piperazine derivatives as novel isoform selective voltage-gated sodium (Nav) 1.3 channel modulators, Medicinal Chemistry Research, 2015, 24, 6, 2366

    CrossRef

  3. 3
    Vaskar Das, Molecular and Cell Biology of Pain, 2015,

    CrossRef

  4. 4
    Jun-Ho Lee, Chul-Kyu Park, Gang Chen, Qingjian Han, Rou-Gang Xie, Tong Liu, Ru-Rong Ji, Seok-Yong Lee, A Monoclonal Antibody that Targets a NaV1.7 Channel Voltage Sensor for Pain and Itch Relief, Cell, 2014, 157, 6, 1393

    CrossRef

  5. 5
    Joe A Kaczmarski, Ben Corry, Investigating the size and dynamics of voltage-gated sodium channel fenestrations, Channels, 2014, 8, 3, 264

    CrossRef

  6. 6
    Céline Boiteux, Igor Vorobyov, Toby W. Allen, Ion conduction and conformational flexibility of a bacterial voltage-gated sodium channel, Proceedings of the National Academy of Sciences, 2014, 111, 9, 3454

    CrossRef

  7. 7
    Todor Dudev, Carmay Lim, Ion Selectivity Strategies of Sodium Channel Selectivity Filters, Accounts of Chemical Research, 2014, 47, 12, 3580

    CrossRef

  8. 8
    C. Boiteux, I. Vorobyov, R. J. French, C. French, V. Yarov-Yarovoy, T. W. Allen, Local anesthetic and antiepileptic drug access and binding to a bacterial voltage-gated sodium channel, Proceedings of the National Academy of Sciences, 2014, 111, 36, 13057

    CrossRef

  9. 9
    Rong Chen, Ganna Gryn’ova, Yingliang Wu, Michelle L. Coote, Shin-Ho Chung, Mechanisms and Energetics of Potassium Channel Block by Local Anesthetics and Antifungal Agents, Biochemistry, 2014, 53, 43, 6786

    CrossRef

  10. 10
    K. B. Akondi, R. J. Lewis, P. F. Alewood, Re-engineering the μ-conotoxin SIIIA scaffold, Biopolymers, 2014, 101, 4
  11. 11
    Nace Zidar, Žiga Jakopin, David J. Madge, Fiona Chan, Jan Tytgat, Steve Peigneur, Marija Sollner Dolenc, Tihomir Tomašić, Janez Ilaš, Lucija Peterlin Mašič, Danijel Kikelj, Substituted 4-phenyl-2-aminoimidazoles and 4-phenyl-4,5-dihydro-2-aminoimidazoles as voltage-gated sodium channel modulators, European Journal of Medicinal Chemistry, 2014, 74, 23

    CrossRef

  12. 12
    Henrik S. Jensen, Morten Grunnet, Jesper F. Bastlund, Therapeutic potential of NaV1.1 activators, Trends in Pharmacological Sciences, 2014, 35, 3, 113

    CrossRef

  13. 13
    Kevin Armstrong, A Primer on Local Anesthetics for Plastic Surgery, Clinics in Plastic Surgery, 2013, 40, 4, 515

    CrossRef

  14. 14
    S. Yang, Y. Xiao, D. Kang, J. Liu, Y. Li, E. A. B. Undheim, J. K. Klint, M. Rong, R. Lai, G. F. King, Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models, Proceedings of the National Academy of Sciences, 2013, 110, 43, 17534

    CrossRef

  15. 15
    Sharan K. Bagal, Alan D. Brown, Peter J. Cox, Kiyoyuki Omoto, Robert M. Owen, David C. Pryde, Benjamin Sidders, Sarah E. Skerratt, Edward B. Stevens, R. Ian Storer, Nigel A. Swain, Ion Channels as Therapeutic Targets: A Drug Discovery Perspective, Journal of Medicinal Chemistry, 2013, 56, 3, 593

    CrossRef

  16. 16
    Tihomir Tomašić, Basil Hartzoulakis, Nace Zidar, Fiona Chan, Robert W. Kirby, David J. Madge, Steve Peigneur, Jan Tytgat, Danijel Kikelj, Ligand- and Structure-Based Virtual Screening for Clathrodin-Derived Human Voltage-Gated Sodium Channel Modulators, Journal of Chemical Information and Modeling, 2013, 53, 12, 3223

    CrossRef

  17. 17
    Žiga Hodnik, Tihomir Tomašić, Lucija Peterlin Mašič, Fiona Chan, Robert W. Kirby, David J. Madge, Danijel Kikelj, Novel state-dependent voltage-gated sodium channel modulators, based on marine alkaloids from Agelas sponges, European Journal of Medicinal Chemistry, 2013, 70, 154

    CrossRef

  18. 18
    Fan Zhang, Xunxun Xu, Tingting Li, Zhonghua Liu, Shellfish Toxins Targeting Voltage-Gated Sodium Channels, Marine Drugs, 2013, 11, 12, 4698

    CrossRef

  19. 19
    Yoshihiko Nakatani, Haruka Masuko, Taku Amano, The Effect of Lamotrigine on Nav1.4 Voltage-Gated Sodium Channels, Journal of Pharmacological Sciences, 2013, 123, 2, 203

    CrossRef

  20. 20
    K. McCormack, S. Santos, M. L. Chapman, D. S. Krafte, B. E. Marron, C. W. West, M. J. Krambis, B. M. Antonio, S. G. Zellmer, D. Printzenhoff, K. M. Padilla, Z. Lin, P. K. Wagoner, N. A. Swain, P. A. Stupple, M. de Groot, R. P. Butt, N. A. Castle, Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels, Proceedings of the National Academy of Sciences, 2013, 110, 29, E2724

    CrossRef

  21. 21
    Antonio Nardi, Nils Damann, Torsten Hertrampf, Achim Kless, Advances in Targeting Voltage-Gated Sodium Channels with Small Molecules, ChemMedChem, 2012, 7, 10
  22. 22
    Matt J. Craner, Lars Fugger, Misfiring in multiple sclerosis, Annals of Neurology, 2012, 71, 4
  23. 23
    Julie K. Klint, Sebastian Senff, Darshani B. Rupasinghe, Sing Yan Er, Volker Herzig, Graham M. Nicholson, Glenn F. King, Spider-venom peptides that target voltage-gated sodium channels: Pharmacological tools and potential therapeutic leads, Toxicon, 2012, 60, 4, 478

    CrossRef

  24. 24
    Sulayman D. Dib-Hajj, Yang Yang, Joel A. Black, Stephen G. Waxman, The NaV1.7 sodium channel: from molecule to man, Nature Reviews Neuroscience, 2012, 14, 1, 49

    CrossRef

  25. 25
    N. Lenkey, R. Karoly, N. Epresi, ES. Vizi, A. Mike, Binding of sodium channel inhibitors to hyperpolarized and depolarized conformations of the channel, Neuropharmacology, 2011, 60, 1, 191

    CrossRef

  26. 26
    Jonathan W. Theile, Brian W. Jarecki, Andrew D. Piekarz, Theodore R. Cummins, Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navβ4 peptide-mediated resurgent sodium currents, The Journal of Physiology, 2011, 589, 3
  27. 27
    Ryoko Shinohara, Takafumi Akimoto, Osamu Iwamoto, Takatsugu Hirokawa, Mari Yotsu-Yamashita, Kaoru Yamaoka, Kazuo Nagasawa, Synthesis of Skeletal Analogues of Saxitoxin Derivatives and Evaluation of Their Inhibitory Activity on Sodium Ion Channels NaV1.4 and NaV1.5, Chemistry - A European Journal, 2011, 17, 43
  28. 28
    D. Shaya, M. Kreir, R. A. Robbins, S. Wong, J. Hammon, A. Bruggemann, D. L. Minor, Voltage-gated sodium channel (NaV) protein dissection creates a set of functional pore-only proteins, Proceedings of the National Academy of Sciences, 2011, 108, 30, 12313

    CrossRef

  29. 29
    Alistair Mathie, Ion channels as novel therapeutic targets in the treatment of pain, Journal of Pharmacy and Pharmacology, 2010, 62, 9
  30. 30
    Steve England, David Rawson, Isoform-selective voltage-gated Na+channel modulators as next-generation analgesics, Future Medicinal Chemistry, 2010, 2, 5, 775

    CrossRef

  31. 31
    Gillian Burgess, Dic Williams, The discovery and development of analgesics: new mechanisms, new modalities, Journal of Clinical Investigation, 2010, 120, 11, 3753

    CrossRef

  32. 32
    Mark I. Kemp, 2010,

    CrossRef